161 related articles for article (PubMed ID: 11337936)
1. Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms.
Fretland AJ; Leff MA; Doll MA; Hein DW
Pharmacogenetics; 2001 Apr; 11(3):207-15. PubMed ID: 11337936
[TBL] [Abstract][Full Text] [Related]
2. Effects of single nucleotide polymorphisms in human N-acetyltransferase 2 on metabolic activation (O-acetylation) of heterocyclic amine carcinogens.
Hein DW; Fretland AJ; Doll MA
Int J Cancer; 2006 Sep; 119(5):1208-11. PubMed ID: 16570281
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.
Zang Y; Doll MA; Zhao S; States JC; Hein DW
Carcinogenesis; 2007 Aug; 28(8):1665-71. PubMed ID: 17434923
[TBL] [Abstract][Full Text] [Related]
4. Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.
Walraven JM; Zang Y; Trent JO; Hein DW
Curr Drug Metab; 2008 Jul; 9(6):471-86. PubMed ID: 18680467
[TBL] [Abstract][Full Text] [Related]
5. Functional genomics of C190T single nucleotide polymorphism in human N-acetyltransferase 2.
Zhu Y; Doll MA; Hein DW
Biol Chem; 2002 Jun; 383(6):983-7. PubMed ID: 12222688
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
Hein DW; Doll MA; Rustan TD; Ferguson RJ
Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
[TBL] [Abstract][Full Text] [Related]
7. The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure.
Hein DW; Salazar-González RA; Doll MA; Zang Y
Arch Toxicol; 2023 Oct; 97(10):2697-2705. PubMed ID: 37592049
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2.
Zang Y; Zhao S; Doll MA; States JC; Hein DW
Pharmacogenet Genomics; 2007 Jan; 17(1):37-45. PubMed ID: 17264801
[TBL] [Abstract][Full Text] [Related]
9. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
Hein DW; Doll MA
Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
[TBL] [Abstract][Full Text] [Related]
10. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
11. N-acetyl transferase 2/environmental factors and their association as a modulating risk factor for sporadic colon and rectal cancer.
Procopciuc LM; Osian G; Iancu M
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27883249
[TBL] [Abstract][Full Text] [Related]
12. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
Jefferson FA; Xiao GH; Hein DW
Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
[TBL] [Abstract][Full Text] [Related]
13. Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms.
García-Martín E
Curr Drug Metab; 2008 Jul; 9(6):487-97. PubMed ID: 18680468
[TBL] [Abstract][Full Text] [Related]
14. The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation.
Zang Y; Zhao S; Doll MA; States JC; Hein DW
Pharmacogenetics; 2004 Nov; 14(11):717-23. PubMed ID: 15564878
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1.
Fretland AJ; Doll MA; Leff MA; Hein DW
Pharmacogenetics; 2001 Aug; 11(6):511-20. PubMed ID: 11505221
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes.
Hein DW; Ferguson RJ; Doll MA; Rustan TD; Gray K
Hum Mol Genet; 1994 May; 3(5):729-34. PubMed ID: 8081359
[TBL] [Abstract][Full Text] [Related]
18. Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype.
Leff MA; Fretland AJ; Doll MA; Hein DW
J Biol Chem; 1999 Dec; 274(49):34519-22. PubMed ID: 10574910
[TBL] [Abstract][Full Text] [Related]
19. Recombinant expression and catalytic analysis of rapid and slow acetylator Syrian hamster chimeric NAT2 alleles.
Hein DW; Ferguson RJ; Doll MA; Deitz AC
Arch Toxicol; 1997; 71(5):306-13. PubMed ID: 9137809
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
Hein DW
Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
